Plasma glial fibrillary acidic protein and tau: predictors of neurological outcome after cardiac arrest

Isabelle Arctaedius,Helena Levin,Bergthóra Thorgeirsdóttir,Marion Moseby-Knappe,Tobias Cronberg,Martin Annborn,Niklas Nielsen,Henrik Zetterberg,Kaj Blennow,Nicholas J. Ashton,Attila Frigyesi,Hans Friberg,Anna Lybeck,Niklas Mattsson-Carlgren
DOI: https://doi.org/10.1186/s13054-024-04889-0
IF: 15.1
2024-04-11
Critical Care
Abstract:The purpose was to evaluate glial fibrillary acidic protein (GFAP) and total-tau in plasma as predictors of poor neurological outcome after out-of-hospital (OHCA) and in-hospital cardiac arrest (IHCA), including comparisons with neurofilament light (NFL) and neuron-specific enolase (NSE).
critical care medicine
What problem does this paper attempt to address?
This paper aims to evaluate the roles of glial fibrillary acidic protein (GFAP) and total tau protein in predicting adverse neurological prognoses after cardiac arrest. The research subjects include out - of - hospital cardiac arrest (OHCA) and in - hospital cardiac arrest (IHCA) patients. Specifically, researchers collect blood samples at different time points after cardiac arrest (upon admission to the ICU, at 12 hours, and at 48 hours), analyze the levels of these biomarkers, and compare them with neuron - specific enolase (NSE) and neurofilament light - chain protein (NFL) to evaluate their predictive abilities. In addition, the study also explores whether combining different biomarkers from astrocytes and neurons can improve the prediction accuracy. ### Research Background After cardiac arrest, the most common cause of death is brain injury. Life - support treatment is usually withdrawn after predicting an adverse neurological prognosis. Currently, the ERC/ESICM guidelines recommend multimodal neurological prognosis assessment at 72 hours after cardiac arrest, combining clinical examinations, brain - injury biomarkers, neurophysiological examinations, and neuroimaging results. However, existing biomarkers such as NSE can only provide predictive value 48 - 72 hours after cardiac arrest. Therefore, it is of great significance to find earlier and more accurate biomarkers. ### Research Objectives 1. **Evaluate the roles of GFAP and tau protein in predicting the neurological prognoses of OHCA and IHCA patients**. 2. **Compare the predictive abilities of GFAP and tau protein with those of NSE and NFL**. 3. **Explore whether combining different biomarkers can improve the prediction accuracy**. ### Main Findings - **GFAP**: - At 12 hours and 48 hours after cardiac arrest, GFAP has a relatively high ability to predict the neurological prognoses of OHCA patients. Especially at 48 hours, the AUC reaches 0.91 (95% CI 0.87 - 0.96). - For IHCA patients, GFAP also has a relatively good predictive ability at 48 hours, with an AUC of 0.83 (95% CI 0.71 - 0.95). - The predictive ability of GFAP at 12 hours is equivalent to that of NSE at 48 hours. - **tau protein**: - Tau protein has the highest predictive ability at 48 hours. For OHCA patients, the AUC is 0.93 (95% CI 0.89 - 0.96), and for IHCA patients, the AUC is 0.77 (95% CI 0.65 - 0.90). - The predictive ability of tau protein at 12 hours is relatively low, but it performs well at 48 hours. - **Combined Biomarkers**: - Combining GFAP and tau protein or GFAP and NFL does not significantly improve the prediction accuracy, but the consistency of multiple biomarkers can increase the safety of clinical decision - making. ### Conclusion GFAP and tau protein are reliable biomarkers for neurological prognoses after cardiac arrest. In particular, the predictive ability of GFAP at 12 hours has already shown relatively high value. These biomarkers may contribute to earlier multimodal neurological prognosis assessment, thereby improving the management and treatment decisions of cardiac arrest patients.